Welcome to our dedicated page for Levi Strauss & Co. SEC filings (Ticker: LEVI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Levi Strauss & Co. (NYSE: LEVI) SEC filings page brings together the company’s regulatory disclosures, which provide detailed insight into its operations as one of the world’s largest brand-name apparel companies and a global leader in jeanswear. Through documents such as Forms 8-K, 10-K and 10-Q, Levi Strauss & Co. reports on financial performance, capital structure, governance decisions and other material events affecting the business.
Recent Form 8-K filings illustrate the range of topics covered. The company has furnished earnings releases for quarterly results, outlining net revenue trends, regional performance, direct-to-consumer and e-commerce growth, margin metrics and updated guidance. Other 8-Ks describe leadership and governance changes, including the appointment or retirement of directors, new executive roles and related compensation arrangements under the 2019 Equity Incentive Plan.
Levi Strauss & Co. also uses 8-K filings to disclose financing and capital markets activities. For example, a July 2025 8-K details the issuance of €475 million 4.000% Senior Notes due 2030, including interest terms, redemption options, covenants and the use of proceeds to redeem existing notes. Additional filings address matters such as the frequency of shareholder advisory votes on executive compensation, reflecting board decisions following shareholder meetings.
On Stock Titan, these filings can be viewed alongside AI-powered summaries that highlight key points, explain technical language and point to items of potential interest, such as changes in leverage, governance structures or compensation policies. Users can quickly locate Levi Strauss & Co.’s annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and other exhibits, and can track how the company communicates financial results, strategic initiatives and governance developments to regulators and investors over time.
Ming Jenny J, a director of Levi Strauss & Co. (LEVI), reported insider acquisitions on 08/08/2025 consisting of dividend equivalent rights (DERs) tied to the company's common stock. The filing shows the reporting person acquired 82 DERs that represent contingent rights to receive Class A common stock and 110 DERs that represent contingent rights to receive Class B common stock; the Class B DERs are noted as fully vested and subject to a deferral delivery feature. The report lists 64,442 shares of Class A common stock beneficially owned following the non-derivative transaction and 59,775 derivative securities beneficially owned following the reported derivative transaction. Each share of Class B common stock is convertible into one share of Class A common stock per the filing.
Christopher J. McCormick, a director of Levi Strauss & Co. (LEVI), reported awards and related contingent dividend-equivalent rights on 08/08/2025. The filing shows the acquisition of 213 dividend equivalent rights (DERs) tied to Class A Common Stock and 41 DERs tied to Class B Common Stock, both reported as acquired at a $0.00 price. After these transactions, the report lists 70,103 shares of Class A Common Stock and 57,464 shares (or equivalents) of Class A Common Stock underlying Class B holdings as beneficially owned directly. The DERs vest and settle consistent with underlying awards; unvested awards vest on the earlier of the day before the next annual meeting or one year after grant, and some DERs are fully vested but subject to deferred delivery.
Form 4 summary for LEVI: David S. Marberger, a director of Levi Strauss & Co., acquired 102 dividend equivalent rights (DERs) on 08/08/2025. Each DER represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The reported transaction increases the reporting person’s direct beneficial ownership to 22,645 shares following the reported transaction.
The DERs vest and are delivered consistent with the underlying awards: unvested awards and related DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. Certain underlying awards are fully vested but subject to deferred delivery; the same delivery terms apply to the related DERs.
Insider acquisition reported: Director Daniel W. Geballe acquired 80 dividend equivalent rights (DERs) tied to Levi Strauss & Co. Class A common stock on 08/08/2025. Each DER is a contingent right to receive one share upon settlement; the DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the related grant. The reported acquisition carried a $0.00 price and increased Mr. Geballe's direct beneficial ownership to 11,634 Class A shares. Some underlying awards may include a deferred delivery feature that applies equally to the DERs.
Garten Yael, a director of Levi Strauss & Co. (LEVI), reported the acquisition of 107 dividend equivalent rights (DERs) on 08/08/2025. Each DER is a contingent right to receive one share of the issuer's Class A Common Stock upon settlement; the transaction shows a price of $0.00 and the reporting table indicates 60,362 shares beneficially owned following the reported transaction, held directly.
The filing explains that the DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and related DERs vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the grant date; certain underlying awards are fully vested but subject to deferred delivery, and those same terms apply to the related DERs.
Spencer C. Fleischer, a director of Levi Strauss & Co. (LEVI), reported acquisitions of dividend equivalent rights that will convert into common stock upon settlement. On 08/08/2025 he acquired 213 DERs tied to Class A Common Stock and 187 DERs tied to Class B Common Stock, each recorded with a transaction code A and a price of $0.00. Following these acquisitions the report shows 64,500 shares of Class A Common Stock beneficially owned and 116,515 shares underlying derivative securities beneficially owned. The filing explains that DERs represent contingent rights to receive one share per DER upon settlement, vesting consistent with underlying awards and subject in some cases to deferred delivery, and notes Class B shares convert one-for-one into Class A shares.
Levi Strauss & Co. Form 4: Director Robert Eckert reported acquisitions tied to dividend equivalent rights (DERs) on 08/08/2025. The filing shows an acquisition of 346 DERs relating to Class A Common Stock at $0.00, after which Mr. Eckert is reported to beneficially own 93,815 shares of Class A Common Stock. The filing also reports acquisition of 309 DERs relating to Class B Common Stock (convertible one-for-one into Class A) at $0.00, with 219,098 derivative securities reported as beneficially owned following the transaction.
The explainers state that DERs are contingent rights to receive one share upon settlement and vest consistent with the underlying awards; some underlying awards are fully vested but subject to deferred delivery. The form was signed by an attorney-in-fact on 08/12/2025.
Jill Beraud, a director of Levi Strauss & Co. (LEVI), filed a Form 4 disclosing acquisitions on 08/08/2025. The filing reports the acquisition of 82 dividend equivalent rights (DERs) tied to Class A Common Stock at a reported price of $0.00; after the transaction she beneficially owned 172,616 Class A shares directly. The filing also reports acquisition of 97 DERs tied to Class B Common Stock (each Class B share convertible into one Class A share) at $0.00; the filing shows 14,095 derivative securities beneficially owned following the transaction.
The Form explains the 82 DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the underlying award, while the 97 DERs are fully vested and the underlying Class B shares issuable pursuant to those DERs are subject to a deferral delivery feature. The Form was filed by one reporting person and signed by an attorney-in-fact on 08/12/2025.
Alstead Troy, a director of Levi Strauss & Co. (LEVI), reported acquisitions on Form 4 dated 08/08/2025. The filing shows the acquisition of 82 dividend equivalent rights (DERs) tied to Class A common stock and 320 DERs tied to Class B common stock.
After the transactions the report lists 122,616 shares of Class A common stock beneficially owned and 46,169 derivative securities beneficially owned. The Class A DERs vest 100% on the earlier of the day before the next annual meeting or the first anniversary of grant; the Class B DERs are fully vested and the underlying Class B shares are convertible into Class A shares and subject to a deferred delivery feature. The form is signed by an attorney-in-fact on 08/12/2025.
Rodgers Elliott, a director of Levi Strauss & Co. (LEVI), reported acquisitions of Class A common stock. On 08/07/2025 he acquired 233 shares through a dividend reinvestment program at a per-share price of $20.135. On 08/08/2025 he received 116 dividend equivalent rights (DERs) at a reported price of $0.00. The DERs are contingent rights to receive one share upon settlement and vest and are delivered consistent with the underlying awards, generally vesting by the earlier of the day before the next annual stockholder meeting or the first anniversary of grant; some underlying awards are fully vested but subject to deferred delivery. Following these reported transactions, Elliott's direct beneficial ownership is 50,558 Class A shares.